The Effectiveness of a Herbal Supplement in Osteoarthritis.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMiddlesex University

About this trial

This study aims to evaluate the effectiveness and safety of a combined herbal supplement containing Boswellia serrata, Curcuma longa, and Vitis vinifera in adults with clinically diagnosed knee or hip osteoarthritis.

The primary objective is to determine whether the supplement improves osteoarthritis-related symptoms.

The supplement will be compared with a placebo.

Participants will:

* take the supplement and placebo for 4 weeks each, one at a time; * complete validated questionnaires (6 times online) * perform three performance-based physical tests (6 times online) * provide a urine sample

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged ≥ 18

Diagnosis of osteoarthritis in knee or hip

Numerical Rating Scale (NRS) ≥ 4 during the most painful movement in the last 24 hours

Lequesne's Functional Index (LFI) score ≥ 7

Disqualifiers

Pregnant and breastfeeding

Autoimmune disease such as rheumatoid arthritis, gout, lupus

Joint trauma, joint injury, joint infection, meniscus tear, complete loss of articular cartilage

Expectation of surgery

Trial design

Design model

Crossover

Treatments tested in this trial

  • Active treatment

    Dietary supplement

    A dietary supplement containing standardised herbal extracts of Boswellia serrata (525 mg), Curcuma longa (150 mg), Vitis vinifera (75 mg). Four times a day.

  • Placebo

    Other intervention

    A placebo containing no standardised herbal extracts or other active ingredients. Four times a day.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Active TreatmentExperimental treatment 1 intervention
Group B: PlaceboPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Western Ontario and McMaster Universities Arthritis Index (WOMAC) score

Western Ontario and McMaster Universities Arthritis Index, a validated, specialised instrument used to assess pain, stiffness, and physical function in people with osteoarthritis. Scores range from 0 to 96 (Likert version), with higher scores indicating worse pain (0-20), stiffness (0-8), and physical function (0-68).

Time frame
Change from the start of the intervention to Week 4 of supplementation
2

Change in Numeric Rating Scale (NRS) score

Numeric Rating Scale. A specialised pain assessment tool, where patients rate their pain intensity on a scale from 0 to 10, where 0 indicates no pain and 10 indicates worst imaginable pain; higher scores indicate worse outcomes.

Time frame
Change from the start of the intervention to Week 4 of supplementation
3

Change in Intermittent and Constant Osteoarthritis Pain knee/hip (ICOAP) score

ICOAP. A Measure of Intermittent and Constant Osteoarthritis Pain knee/hip To assess two distinct types of pain experienced by people with osteoarthritis-intermittent pain (comes and goes, 0 - 24) and constant pain (persistent, ongoing pain, 0 - 20). Scores range from 0 to 44, with higher scores indicating more severe osteoarthritis related pain.

Time frame
Change from the start of the intervention to Week 4 of supplementation
4

Change in EuroQol 5-Dimension 5-Level (EQ-5D-5L) score

EuroQol 5-Dimension 5-Level questionnaire. A generic, widely used tool to measure health-related quality of life. It measures five dimensions: Mobility, Self-care, Usual activities, Pain/discomfort, Anxiety/depression. A score of 1 indicates no problems, while 5 indicates extreme problems in the respective dimension. In addition, the EQ Visual Analogue Scale (EQ-VAS) records the respondent's self-rated health on a vertical scale ranging from 0 to 100, where 0 represents the worst imaginable health state and 100 represents the best imaginable health state.

Time frame
Change from the start of the intervention to Week 4 of supplementation

Secondary outcomes

1

Change in Western Ontario and McMaster Universities Arthritis Index (WOMAC) score.

Western Ontario and McMaster Universities Arthritis Index, a validated, specialised instrument used to assess pain, stiffness, and physical function in people with osteoarthritis. Scores range from 0 to 96 (Likert version), with higher scores indicating worse pain (0-20), stiffness (0-8), and physical function (0-68).

Time frame
Change from baseline to the end of Week 1 of supplementation
2

Change in Numeric Rating Scale (NRS) score

Numeric Rating Scale. A specialised pain assessment tool, where patients rate their pain intensity on a scale from 0 to 10, where 0 indicates no pain and 10 indicates worst imaginable pain; higher scores indicate worse outcomes.

Time frame
Change from baseline to the end of Week 1 of supplementation
3

Change in Intermittent and Constant Osteoarthritis Pain knee/hip (ICOAP) score

ICOAP. A Measure of Intermittent and Constant Osteoarthritis Pain knee/hip To assess two distinct types of pain experienced by people with osteoarthritis-intermittent pain (comes and goes, 0 - 24) and constant pain (persistent, ongoing pain, 0 - 20). Scores range from 0 to 44, with higher scores indicating more severe osteoarthritis related pain.

Time frame
Change from baseline to the end of Week 1 of supplementation
4

Change in Lequesne Functional Index (LFI) score

Lequesne Functional Index. A specialised questionnaire used to evaluate the severity of osteoarthritis and its impact on daily function, particularly for the hip and knee. Scores range from 0 to 24, with higher scores indicating greater severity and worse functional impairment.

Time frame
Change from baseline to the end of Week 1 of supplementation

Other outcomes

1

Satisfaction with remotely controlled study

Participants will be asked to complete a remote study satisfaction survey

Time frame
At the end of the study: 12 weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.